Blog
Welcome Mary Anne Gfell to Pearl Pathways
Pearl Pathways is excited to announce the addition of Mary Anne Gfell to the team as a Clinical Research Advisor. Bringing over 15 years of experience in clinical research and quality compliance, Gfell is a key addition to the Pearl Pathways team. Prior to joining...
Check out our new case studies
Interested in learning about how Pearl Pathways has assisted our clients? We have published new case studies featuring pharma, medical device, and academic hospital clients, bringing our total number of case studies to sixteen. You can learn through real life examples...
IMDMC is hosting second workshop on September 10th
The Indiana Medical Device Manufacturers Council is hosting the second of a two-part event on September 10th. The workshop allows participants to hone their skills, while learning more about the background of the industry. This event targets people who are new to the...
Could the Sunshine Act be the cause of decline in research funding?
According to a recent article in News-Medical.net, the Sunshine Act’s new Open Payments plan could potentially be the cause of a dramatic downfall in U.S. clinical research. Research conducted from the U.S. Open Payments database has shown that between 2013 and 2014,...
Positive results in clinical trials down to 8% in recent years
After implementing a new transparency program requiring sponsors to register their trial on Clinicaltrials.gov and identify study outcomes, it was found that only 8% of clinical trials report positive results. Clinical trials performed from 2000 to 2012 reported...